Testing the Therapeutic Potential of Doxycycline in a Drosophila melanogaster Model of Alzheimer Disease
Authors:
- Rita CostaRCRita Costa
- Elena SperettaESElena Speretta
- Damian C. CrowtherDCDamian C. Crowther
- Isabel CardosoICIsabel Cardoso
Open Access
- 1 December 2011
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (48) , 41647-41655
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomersNeurobiology of Disease, 2010
- Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse modelsJournal of Translational Medicine, 2010
- RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10Cell, 2010
- Amyloid-β fibrillogenesis: Structural insight and therapeutic interventionExperimental Neurology, 2010
- The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementiaBrain, 2010
- Alzheimer's disease: insights from Drosophila melanogaster modelsTrends in Biochemical Sciences, 2010
- β-amyloid oligomers and cellular prion protein in Alzheimer’s diseaseJournal of Molecular Medicine, 2009
- Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's diseaseBMC Neuroscience, 2009
- Reassessing the amyloid cascade hypothesis of Alzheimer's diseaseThe International Journal of Biochemistry & Cell Biology, 2009
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008